Skip to main content

Table 1 Patient characteristics

From: CD4+ T cells in aged or thymectomized recipients of allogeneic stem cell transplantations

Variable

Number of patients

Age [median (range), years]

38.5 (23–61)

Male/female

14/8

Diagnosis

 AML/MDS

14

 ALL/ML

8

Donor

 Related

10

 Unrelated

12

Source

 BMT

14

 PBSCT

8

HLA compatibility

 Matched

17

 1-locus mismatch

5

Conditioning

 Myeloablative

14

  TBI/CY-based

10

  BU/CY

4

 Reduced-intensity

8

  TBI/Flu/BU

4

  TBI/Flu/Mel

4

GVHD prophylaxis

 CyA/MTX

3

 TAC/MTX

19

  1. AML/MDS acute myeloid leukemia/myelodysplastic syndromes, ALL/ML acute lymphoblastic leukemia/malignant lymphoma, BMT bone marrow transplantation, PBSCT peripheral blood stem cell transplantation, HLA human leukocyte antigen, TBI total body irradiation, CY cyclophosphamide, BU Busulfan, Mel melphalan, GVHD graft-versus-host disease, CyA cyclosporine A, MTX methotrexate, TAC tacrolimus.
Back to article page

Biological Research

ISSN: 0717-6287

Contact us